United States · FDA National Drug Code directory
Teriparatide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-1106_5e3977c0-a361-494b-ac07-0426dda5bd36
- Product NDC
- 0093-1106
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Teriparatide
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231218
- Source listing expiry
- 20261231
Source-listed ingredients
- TERIPARATIDE ACETATE — 250 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGE · 0093-1106-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →